A kKO40336
: Lf ithroCare
MAR ~ £ 2004 k 04.0338 r. O42
510(k) Summary d
ArthroCare Corporation
ArthroCare System

General Information
Submitter Name/Address: ArthroCare Corporation

680 Vaqueros Avenue

Sunnyvale, CA 94085-3523
Establishment Registration Number: 2951580
Contact Person: Valerie Defiesta-Ng

Director, Regulatory Affairs
Date Prepared: February 9, 2004
Device Description
Trade Name: ArthroCare® System
Generic/Common Name: Electrosurgical Device and Accessories
Classification Name: Electrosurgical Cutting and Coagulation

Device and Accessories (21 CFR 878.4400)
Predicate Devices
arecicate Mevices
ArthroCare” System 2000 K020832 and K030954
Product Description
The ArthroCare System is a bipolar, high frequency electrosurgical system consisting of
three components: an electrosurgical generator called the Controller; a family of
disposable, bipolar, single use Wands; and a reusable Patient Cable.

O50 Vaqueros Avenue # Sunnyvale, CA 94085 © 1-408) 736-0224 © Fax: (408) 736-0226
x

: fy@ 9@
Intended Uses
The ArthroCare Systern is indicated for resection, ablation, and coagulation of soft tissue
and hemostasis of blood vessels in orthopedic, arthroscopic, spinal, and neurological
procedures.
The ArthroCare Systern is indicated for ablation, coagulation, and decompression of disc
material to treat symptomatic patients with contained herniated discs.
Substantial Equivalence
This Special 510(k) proposes a modification in the performance specifications and
labeling for the ArthroCare System 2000, which was previously cleared in K020832 on
April 9, 2002 and K030954 on April 16, 2003. The indications for use, technology,
principle of operation, materials, packaging, and sterilization parameters of the
ArthroCare System remain the same as in the predicate cleared 510(k).
Summary of Safety and Effectiveness
The modified ArthroCare System, as described in this Special 510(k), is substantially
equivalent to the predicate device. The proposed modifications in performance
specifications and labeling are not substantial changes or modifications, and do not
significantly affect the safety or efficacy of the System.

Xi

wa
f DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
LG
te Food and Drug Administration
9200 Corporate Boulevard
MAR ~ 1 2004 Rocvile MD 20850
Ms. Valerie Defiesta-Ng
Director, Regulatory Affairs
ArthroCare Corporation
680 Vaqueros Avenue
Sunnyvale, California 94085-3523
Re: K040338
Trade/Device Name: ArthroCare System
Regulation Number: 21 CFR 878.4400
Regulation Name: Electrosurgical cutting and coagulation device and accessories
Regulatory Class: IL
Product Code: GEI
Dated: February 9, 2004
Received: February 11, 2004
Dear Ms. Defiesta-Ng:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, .
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and .
adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 - Ms. Valerie Defiesta-Ng
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (301) 594-4659, Also, please note the regulation entitled,
"Misbranding by reference to premarket notification” (21CFR Part 807.97). You may obtain
other general information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
(301) 443-6597 or at its Internet address http://www. fda.gov/cdrh/dsma/dsmamain.htm]

Sincerely yours, an

fec M. Witten, Ph.D., M.D.
Director
Division of General, Restorative
and Neurological Devices

Office of Device Evaluation

Center for Devices and Radiological Health
Enclosure

Indications for Use Statement
Koyoza¢

Device Name ArthroCare System

510(k) Number: KO 4-0 33%

Indications for Use:

« The ArthroCare System is indicated for resection, ablation, and coagulation of soft
tissue and hemostasis of blood vessels in orthopedic, arthroscopic, spinal, and
neurological procedures.

= The ArthroCare System is indicated for ablation, coagulation, and decompression of
disc material to treat symptomatic patients with contained herniated discs.

—aT a nS
fr (Division Sign-Off)
Division of General, Restorative,
and Neurological Devices
KOYO3% 7
510(k) Number_______——
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF Nitti) (43)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use xX OR Over-the-Counter Use
(Per 21 CFR 801.109) —
1X

